|Titre :||Addiction, Vol.116, n°7 - July 2021|
|Type de document :||Bulletin : Périodique|
|Paru le :||01/07/2021|
|Année de publication :||2021|
|Note de contenu :||
- WHO should not support alcohol industry co-regulation of public health labelling [Editorial]. O'Brien P., Stockwell T., Vallance K., Room R., p. 1619-1621.
- Unknown population-level harms of cannabis and tobacco co-use: if you don't measure it, you can't manage it [Addiction Opinion and Debate]. Hindocha C., McClure E.A., p. 1622-1630.
- Assessing cannabis and tobacco co-use: the pros and cons of additional data collection. McRobbie H., Boland V.C., Courtney R.J., p. 1631-1633.
- Co-use measurement is also required in treatment interventions. Walsh H., Duaso M.J., p. 1633-1634.
- Co-using drugs-what do we need to know? Najman J.M., p. 1634-1635.
- Accurate and sufficient measurement of cannabis and tobacco co-use: agreement, consensus and the path forward. McClure E.A., p. 1636-1637.
- Are psychosocial interventions effective in reducing alcohol consumption during pregnancy and motherhood? A systematic review and meta-analysis. Ujhelyi Gomez K., Goodwin L., Jackson L., Jones A., Chisholm A., Rose A.K., p. 1638-1663.
- Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta-analysis. Ferraro C.F., Stewart D.E., Grebely J., Tran L.T., Zhou S., Puca C., et al., p. 1664-1676.
- Impact of reducing alcohol consumption through price-based policies on cancer incidence in Germany 2020-50 - A simulation study. Gredner T., Niedermaier T., Brenner H., Mons U., p. 1677-1688.
- A co-twin-control analysis of adolescent and young adult drinking effects on learning and memory. Malone S.M., Wilson S., Bair J.L., McGue M., Iacono W.G., p. 1689-1699.
- Prevalence and patterns of hospital use for people with frequent alcohol-related hospital admissions, compared to non-alcohol and non-frequent admissions: a cohort study using routine administrative hospital data. Blackwood R., Lynskey M., Drummond C., p. 1700-1708.
- When the pubs closed: beer consumption before and after the first and second waves of COVID-19 in Australia. Vandenberg B., Livingston M., O'Brien K., p. 1709-1715.
- Subjective alcohol responses in high- and low-risk adolescents: results from the Dresden Longitudinal Study on Alcohol Use in Young Adults. Chavarria J., Fridberg D.J., Obst E., Zimmermann U.S., King A.C., p. 1716-1724.
- An N-of-1 study of daily alcohol consumption following minimum unit pricing implementation in Scotland. Kwasnicka D., Boroujerdi M., O'Gorman A., Anderson M., Craig P., Bowman L., et al., p. 1725-1733.
- Transfer of incentive salience from a first-order alcohol cue to a novel second-order alcohol cue among individuals at risk for alcohol use disorder: electrophysiological evidence. Fleming K.A., Cofresi R.U., Bartholow B.D., p. 1734-1746.
- Association between poverty exposure during childhood and adolescence, and drug use disorders and drug-related crimes later in life. Manhica H., Straatmann V.S., Lundin A., Agardh E., Danielsson A.K., p. 1747-1756.
- A US national randomized study to guide how best to reduce stigma when describing drug-related impairment in practice and policy. Kelly J.F., Greene M.C., Abry A., p. 1757-1767.
- Commentary on Kelly et al.: The struggle to define or be defined. Livingston J.D., p. 1768-1769.
- First-time offenders for recreational ketamine use under a new penalty system in Taiwan: incidence, recidivism and mortality in national cohorts from 2009 to 2017. Pan W.H., Wu K.C., Chen C.Y., Chu Y.R., Wu S.C., Jou S., et al., p. 1770-1781.
- Heterogeneities in administration methods among cannabis users by use purpose and state legalization status: findings from a nationally representative survey in the United States, 2020. Shi Y., p. 1782-1793.
- Craving mediates the association between momentary pain and illicit opioid use during treatment for opioid-use disorder: an ecological momentary assessment study. Mun C.J., Finan P.H., Epstein D.H., Kowalczyk W.J., Agage D., Letzen J.E., et al., p. 1794-1804.
- Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network. Wu L.T., John W.S., Ghitza U.E., Wahle A., Matthews A.G., Lewis M., et al., p. 1805-1816.
- Laws limiting prescribing and dispensing of opioids in the United States, 1989-2019. Davis C.S., Lieberman A.J., p. 1817-1827.
- Factors associated with severity, incidence or persistence of internet gaming disorder in children and adolescents: a 2-year longitudinal study. Jeong H., Yim H.W., Lee S.Y., Lee H.K., Potenza M.N., Lee H., p. 1828-1838.
- Association between age at first reported e-cigarette use and subsequent regular e-cigarette, ever cigarette and regular cigarette use. Conner M., Grogan S., Simms-Ellis R., Cowap L., Armitage C.J., West R., et al., p. 1839-1847.
- Trends in electronic cigarette use and conventional smoking: quantifying a possible 'diversion' effect among US adolescents. Selya A.S., Foxon F., p. 1848-1858.
- Dependence on nicotine in US high school students in the context of changing patterns of tobacco product use. Jackson S.E., Brown J., Jarvis M.J., p. 1859-1870.
- Education tracking and adolescent smoking: a counterfactual and prospective cohort study. Lin W.H., Gebel M., p. 1871-1881.
- Alcohol and tobacco consumption: What is the role of economic security? Bentley R., Baker E., Martino E., Li Y., Mason K., p. 1882-1891.
- Building a hospital-based addiction medicine consultation service in Vancouver, Canada: the path taken and lessons learned. Braithwaite V., Ti L., Fairbairn N., Ahamad K., McLean M., Harrison S., et al., p. 1892-1900.
- Emergence of wasp dope in rural Appalachian Kentucky. Young A.M., Livingston M., Vickers-Smith R., Cooper H.L.F., p. 1901-1907.
- Availability of medical cannabis dispensaries and cannabis abuse/dependence-related hospitalizations in California. Mair C., Sumetsky N., Kranich C., Freisthler B., p. 1908-1913.
- Injecting drug use, the skin and vasculature. Robertson R., Broers B., Harris M., p. 1914-1924.
- Scandalous decisions: explaining shifts in UK medicinal cannabis policy. Monaghan M., Wincup E., Hamilton I., p. 1925-1933.
DépouillementsAjouter le résultat dans votre panier
Article : Périodique
BACKGROUND: Nationally representative data of cannabis-tobacco co-use have shown that these substances are closely entwined and have significant adverse health consequences, although population-level harms of co-use are largely unknown. Current [...]
Article : Périodique
K. UJHELYI GOMEZ ; L. GOODWIN ; L. JACKSON ; A. JONES ; A. CHISHOLM ; A. K. ROSE |
BACKGROUND AND AIMS: Alcohol use by pregnant and parenting women can have serious and long-lasting consequences for both the mother and offspring. We reviewed the evidence for psychosocial interventions to reduce maternal drinking. DESIGN: Lite[...]
Article : Périodique
BACKGROUND AND AIMS: Alcohol is a major cancer risk factor and contributes considerably to the cancer burden in Germany. We aimed to provide projections of preventable cancer cases under different price-based alcohol policy scenarios. DESIGN: A[...]
Article : Périodique
H. MANHICA ; V. S. STRAATMANN ; A. LUNDIN ; E. AGARDH ; A. K. DANIELSSON |
AIMS: To examine whether poverty exposure in childhood/adolescence increases the risk of later drug use disorder and drug crime conviction. DESIGN, SETTING AND PARTICIPANTS: A national cohort study encompassing 634 284 individuals born between [...]